U.S. World Business Lifestyle
Today: July 22, 2026
Today: July 22, 2026

FDA

Health|World

Anti-abortion activists meet White House officials amid frustration over Trump agenda

Frustrated abortion opponents met with White House officials on Friday amid growing criticism in the anti-abortion movement that

Anti-abortion activists meet White House officials amid frustration over Trump agenda
Health|Science

FDA's new playbook: Lots of media announcements but not much rulemaking

Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted

FDA's new playbook: Lots of media announcements but not much rulemaking
Health|Science|Sports|Technology

Can peptide injections help people recover from injuries? Here’s what you need to know

The internet is awash with claims about injectable peptides for fitness, but there’s almost no human research showing they work or are truly safe.

Can peptide injections help people recover from injuries? Here’s what you need to know
Business|Health|Political|US

Trump pressures FDA's Makary to approve flavored vapes, WSJ reports

U.S.

Trump pressures FDA's Makary to approve flavored vapes, WSJ reports
Business|Economy|Health|Science

FDA Commissioner Makary defends agency's decision on Replimune's drug, CNBC reports

U.S. Food and Drug Administration Commissioner Dr. Marty Makary on Tuesday defended the agency's decision to not approve Replimune's drug for advanced skin cancer.

FDA Commissioner Makary defends agency's decision on Replimune's drug, CNBC reports
Health|Science|US|World

What is mifepristone?

What is mifepristone?

What is mifepristone?
Business|Health|Science

US FDA taps Szarama as acting head of vaccine unit

The U.S.

US FDA taps Szarama as acting head of vaccine unit
Health|Science|World

US FDA moves to fast-track psychedelic drugs after Trump order

The U.S. health regulator on Friday moved to speed up the development of new treatments for serious mental illness by awarding the national

US FDA moves to fast-track psychedelic drugs after Trump order
Business|Health|Political|Science|World

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression

FDA plans ultra-fast review of three psychedelic drugs following Trump directive
Business|Health|Science|Technology|US

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition
Business|Economy|Finance|Health|Political|Science|Stock Markets|US

Psychedelic drug developers rally after Trump orders FDA to expedite reviews

Shares of psychedelic drug developers rose on Monday after U.S.

Psychedelic drug developers rally after Trump orders FDA to expedite reviews
Business|Economy|Health|Science|Technology

US nicotine pouch fast-track scheme slowed by worries over youth, new users

Popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug

US nicotine pouch fast-track scheme slowed by worries over youth, new users
Business|Economy|Health|Political|World

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

President Donald Trump signed an executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S. unless

Drugmakers face 100% tariff unless they cut prices or produce drugs in US
Economy|Health|Science|Technology

Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online
Health|Lifestyle|Political|Science

Kratom poisonings surged 1,200% over the past decade, and regulators are struggling to keep up with the dangers

Conflicting claims about kratom are widespread, but scientific evidence makes the risks clear.

Kratom poisonings surged 1,200% over the past decade, and regulators are struggling to keep up with the dangers
Economy|Environment|Health|Science

Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants

The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency

Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
Education|Health|Political|Science

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment
Health|Science|Technology

FDA’s controversial vaccine chief will exit agency next month

FDA’s controversial vaccine chief will exit agency next month

FDA’s controversial vaccine chief will exit agency next month
Business|Health|Science|World

Trump administration's embattled FDA vaccine chief is leaving for the second time

The Food and Drug Administration’s controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency

Trump administration's embattled FDA vaccine chief is leaving for the second time
Business|Education|Health|Lifestyle|Political|Science

Leucovorin prescriptions surged after the White House touted the drug for autism. Parents are still scrambling to find it

Leucovorin prescriptions surged after the White House touted the drug for autism. Parents are still scrambling to find it

Leucovorin prescriptions surged after the White House touted the drug for autism. Parents are still scrambling to find it
Entertainment|Health|Lifestyle|Science

Family pushes for change after rare disease clinical trial abruptly ends

Family pushes for change after rare disease clinical trial abruptly ends

Family pushes for change after rare disease clinical trial abruptly ends
Business|Environment|Food|Health|Science

Target will stop selling cereals with synthetic colors by end of May

Target will stop selling cereals containing synthetic colors by the end of May

Target will stop selling cereals with synthetic colors by end of May
Business|Health|Science|Technology

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

FDA to offer bonus payments to staffers who complete speedy drug reviews
Business|Health|Science|Technology|World

FDA proposes new system for approving customized drugs and therapies for rare diseases

The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases

FDA proposes new system for approving customized drugs and therapies for rare diseases
Business|Economy|Health|Science|Technology

FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

After pushback, the agency reversed course and agreed to review Moderna’s application after all.

FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
Business|Economy|Health|Science|Technology

FDA reverses course and will review Moderna’s mRNA flu shot, company says

FDA reverses course and will review Moderna’s mRNA flu shot, company says

FDA reverses course and will review Moderna’s mRNA flu shot, company says
Business|Health|Lifestyle|Science|Technology

Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug

Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill
Business|Environment|Food|Health|Science

Companies can now claim 'no artificial colors' if they add plant-based color to food

The U.S. Food and Drug Administration is relaxing rules that restrict when food companies can claim their products have no artificial colors

Companies can now claim 'no artificial colors' if they add plant-based color to food
Business|Economy|Education|Environment|Health|Lifestyle|Science

Botulism outbreak sickens more than 50 babies and expands to all ByHeart products

Federal health officials have expanded an outbreak of infant botulism tied to ByHeart baby formula to include any illnesses reported since the company began production in 2022

Botulism outbreak sickens more than 50 babies and expands to all ByHeart products
Health|Science

FDA in turmoil after exit of veteran cancer researcher

FDA in turmoil after exit of veteran cancer researcher

FDA in turmoil after exit of veteran cancer researcher
Business|Health|Science|US

FDA appoints Tracy Hoeg as acting director of drug evaluation center

The U.S.

FDA appoints Tracy Hoeg as acting director of drug evaluation center
Health|Science|World

A dozen former FDA leaders lambaste claims by the agency's current vaccine chief

A dozen prior leaders of the U.S. Food and Drug Administration have issued a scathing denunciation of an FDA memo to staff that made sweeping claims casting doubt on vaccine safety

A dozen former FDA leaders lambaste claims by the agency's current vaccine chief
Business|Health|Science|World

US FDA removes longtime director of over-the-counter drugs office

The U.S. Food and Drug Administration is moving Theresa Michele, longtime director of the office of non-prescription drugs, to a new role, a federal official said on Wednesday.

US FDA removes longtime director of over-the-counter drugs office
Business|Health|Science

FDA’s top drug officer set to exit, weeks into new role

FDA’s top drug officer set to exit, weeks into new role

FDA’s top drug officer set to exit, weeks into new role
Business|Health|Science|US

US FDA's newly appointed drugs chief set to retire

The U.S.

US FDA's newly appointed drugs chief set to retire
Health|Political|Science|World

Top FDA official Pazdur raises alarm about expediting approvals, Washington Post reports

The U.S.

Top FDA official Pazdur raises alarm about expediting approvals, Washington Post reports
Education|Health|Science

I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings

Hormone therapy is not a silver bullet that reverses aging, but it can significantly improve bothersome symptoms that can diminish people’s quality of life.

I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings
Business|Health|Political|Science

RFK Jr. discussed scaling back the role of FDA chief Makary, WSJ reports

Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed scaling back the role of Marty Makary, the U.S.

RFK Jr. discussed scaling back the role of FDA chief Makary, WSJ reports
Health|Science

What’s a ‘black box’ warning? A pharmacologist explains how these labels protect patients

The drug information sheets that the FDA requires companies to produce are living documents that get updated with new information.

What’s a ‘black box’ warning? A pharmacologist explains how these labels protect patients
Health|Science

US health leaders hailed the benefits of hormone therapy for menopause. Doctors are pushing for balance

US health leaders hailed the benefits of hormone therapy for menopause. Doctors are pushing for balance

US health leaders hailed the benefits of hormone therapy for menopause. Doctors are pushing for balance
Business|Health|Science|World

FDA names longtime cancer scientist Pazdur to lead drug center

The Food and Drug Administration has named a longtime regulator of cancer medications to lead the agency’s drug center

FDA names longtime cancer scientist Pazdur to lead drug center
Business|Economy|Health|Lifestyle|Science

ByHeart recalls all baby formula sold nationwide as infant botulism outbreak grows

Baby formula manufacturer ByHeart recalled all of its products sold nationwide Tuesday

ByHeart recalls all baby formula sold nationwide as infant botulism outbreak grows